Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
{{output}}
Background: Calcitonin gene related peptide (CGRP) monoclonal antibodies (mAB) are the first specific migraine prophylactic medication. Erenumab is the only CGRP mAB targeting the CGRP receptor. Clinical data regarding efficacy a... ...
